Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Presentation document (Nov 10, 2025)
[Summary]Consolidated Financial Results for the Six Months Ended September 30, 2025) [Japanese GAAP]
Consolidated Financial Results for Second Quarter (Interim Period) of FY2025 - Supplementary Information
KYORIN and Hinge Bio Enter into a Collaboration and License Agreement of HB2198 in Japan for SLE and other diseases
Topline Results from Phase 3 Clinical Study of KRP-R120 for Interstitial Lung Disease
Summary of Consolidated Financial Results(For the first quarter ended June 30, 2025) [Japanese GAAP]
Consolidated Financial Results for First Quarter of FY2025 - Supplementary Information
Launch of Beova Tablets in Thailand for Overactive Bladder
Notice of Dividends from Retained Earnings
Summary of Consolidated Financial Results(For fiscal year ended March 31, 2025) [Japanese GAAP]
Announcement of Executive Personnel Changes
Notice Regarding Cancellation of Treasury Stock
Notice Regarding Revision to Annual Dividend Forecast (Special Dividend)
Consolidated Financial Results for the Fiscal Year Ended March 31, 2025 (May 12 2025) - Supplementary Information
Notice of Upward Revisions to Earnings Forecasts
KYORIN and Novartis Enter into a Global License Agreement for KRP-M223
Digital Therapeutic Development for Chronic Cough Treatment
KYORIN and Cyrano Therapeutics Enter into an Option Agreement fot CYR-064 for the Treatment of Post-Viral Loss of Smell in Japan
Summary of Financial Results for the third quarter 2025
Consolidated Financial Results for Third Quarter of FY2024 - Supplementary Information